The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...
The newly FDA-approved nasal spray called Spravato is being manufactured by Johnson & Johnson's and is a standalone treatment ...
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
EastEnders has confirmed a devastating storyline involving Phil Mitchell, which will see the character attempt to take his ...
The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the most promising opportunities for life-changing new therapies and ...
President Donald Trump has signed an executive order promising to eliminate what he incorrectly labels “the electric vehicle ...
Asia Raines with Harlee and Harper Women's Association talks about the group's workshop for helping women manage depression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback